A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

Clinical trial NCT03764293 · COMPLETED

Trial details

NCT number: NCT03764293
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced or Metastatic and Unresectable HCC

Start date: 2019-06-10
Primary completion: 2022-02-08
Enrollment: 543

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.